Journal of Molecular and Cellular Cardiology
Volume 46, Issue 3 , Pages 395-404, March 2009

CELF-mediated alternative splicing is required for cardiac function during early, but not later, postnatal life

  • Fulvia Terenzi

      Affiliations

    • Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave. NC10, Cleveland, OH 44195, USA
  • ,
  • Kyle R. Brimacombe

      Affiliations

    • Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave. NC10, Cleveland, OH 44195, USA
  • ,
  • Marc S. Penn

      Affiliations

    • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    • Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
  • ,
  • Andrea N. Ladd

      Affiliations

    • Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave. NC10, Cleveland, OH 44195, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 216 445 3870; fax: +1 216 444 9404.

Received 22 August 2008; received in revised form 11 October 2008; accepted 30 October 2008. published online 25 November 2008.

Abstract 

During the transition from juvenile to adult life, the heart undergoes programmed remodeling at the levels of transcription and alternative splicing. Members of the CUG-BP and ETR-3-like factor (CELF) family have been implicated in driving developmental transitions in alternative splicing of cardiac transcripts during maturation of the heart. Here, we investigated the timing of the requirement for CELF activity in the postnatal heart using a previously described transgenic mouse model (MHC-CELFΔ). In MHC-CELFΔ mice, nuclear CELF activity has been disrupted specifically in the heart by cardiac-specific expression of a dominant negative CELF protein. Longitudinal analyses of two lines of MHC-CELFΔ mice with differing levels of dominant negative protein expression demonstrate that CELF splicing activity is required for healthy cardiac function during juvenile, but not adult, life. Cardiac function, chamber dilation, and heart size all recover with age in the mild line of MHC-CELFΔ mice without a loss of dominant negative protein expression or change in expression of endogenous CELF proteins or known CELF antagonists. This is the first example of a mouse model with genetically induced cardiomyopathy that spontaneously recovers without intervention. Our results suggest that CELF proteins are key players in the integrated gene expression program involved in postnatal cardiac remodeling and maturation.

Abbreviations: CUG-BP1, CUG binding protein 1, ETR-3, ELAV-type RNA binding protein 3, CELF, CUG-BP and ETR-3-like factor, MHC, myosin heavy chain, cTNT, cardiac troponin T, CaMK, Ca2+/calmodulin-dependent kinase, LVESD, left ventricular end systolic dimension, PWS, posterior wall thickness during systole, MBNL, muscleblind-like, Mtmr1, myotubularin related protein 1, Bin1, bridging integrator 1, Mef2A, myocyte enhancer factor 2A

Keywords: Alternative splicing, CELF proteins, Transgenic mice, Cardiomyopathy, Development, Postnatal remodeling

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-2828(08)01400-4

doi:10.1016/j.yjmcc.2008.10.030

Journal of Molecular and Cellular Cardiology
Volume 46, Issue 3 , Pages 395-404, March 2009